The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for S Manoj Kumar Reddy

Promoters of Concord Drugs Limited — S. Nagi Reddy, S. Koni Reddy and S Manoj Kumar Reddy — subscribed to a preferential allotment on November 20, 2025. Together the promoter group acquired 5 lakh equity shares (about 3.8% of expanded equity) and 18 lakh convertible warrants (about 13.7% on a diluted basis). The company's equity share capital rose from 1 crore to 1.3175 crore shares. After the allotment, the promoter group's total holding crossed to roughly 58.74% of the expanded equity base, up from 54.39% earlier. The acquisition was made under Reg 29(2) of the SEBI Takeover Regulations and the company filed the disclosure with BSE on November 22, 2025.